13d
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer
In some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a ...
Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) ...
Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) ...
Early prediction of prognosis in advanced solid tumor patients using tumor growth rates with g score in early phase clinical trials.
Biomarker discordance after neoadjuvant systemic therapy and associated patterns of recurrence. Clinical update related to the first-in-human trial of SYS6002 (CRB-701), a next-generation nectin-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results